This study assessed the relationship between venous leg ulcers (VLUs) and overall survival among patients treated for chronic venous insufficiency.
Methods
Patients with CEAP C2-C6 disease who underwent superficial venous interventions at a single center from May 2016-April 2024 were identified from the Vascular Quality Initiative Varicose Vein Registry. Demographics, comorbidities, and venous disease severity were recorded at the index database procedure. Mortality was recorded from the electronic health record and Social Security Death Index. Patient characteristics and all-cause mortality were compared between VLU (C5-C6) and non-VLU (C2-C4) cohorts.
Results
Among 7084 patients, 8.9% (n = 632) had a VLU history. Compared with non-VLU patients, those with a VLU history were older (p < .001) and disproportionately male (p < .001), Black/African American (p < .001), and Medicaid-insured (p = .009). They had greater body mass indices (p < .001), revised venous clinical severity scores (rVCSS) (p < .001), HASTI scores (p = .015), and work/activity limitations (p < .001). Prior venous thromboembolism (p < .001), anticoagulation use (p < .001), previous varicose vein (VV) treatment (p = .042), and deep venous reflux (DVR) (p < .001) were also more common. Mortality was higher among VLU patients than non-VLU patients (3.6% vs 0.7%, p < .001) over a similar mean follow-up (2.8 vs 3.0 years, p = .070). VLU history was associated with worse survival (HR 5.03, 95% CI [2.96-8.53], p < .001), in addition to older age (p < .001), male sex (p = .003), White race (p = .003), no prior VV treatment (p = .026), anticoagulation use (p < .001), higher rVCSS (p < .001), and DVR (p = .016). After adjusting for these latter variables, VLU history remained independently associated with mortality (adjusted HR 2.01, 95% CI [1.00-4.01], p = .049). Compared with C2, only C6 –not C3-C5 –was associated with increased mortality after multivariable adjustment (adjusted HR 3.40, 95% CI [1.08, 10.69], p = .036).
Conclusion
Among patients undergoing superficial venous interventions, VLUs were associated with a two-fold hazard of all-cause death. The mechanism driving their increased mortality warrants further study.
O’DonnellTFPassmanMAMarstonWA, et al.Management of venous leg ulcers: clinical practice guidelines of the society for vascular surgery® and the American venous forum. J Vasc Surg2014; 60(2): 3S–59S. https://doi.org/10.1016/j.jvs.2014.04.049
CarradiceDMazariFAKSamuelN, et al.Modelling the effect of venous disease on quality of life. Br J Surg2011; 98(8): 1089–1098. https://doi.org/10.1002/bjs.7500
4.
PhyoAZZFreak-PoliRCraigH, et al.Quality of life and mortality in the general population: a systematic review and meta-analysis. BMC Public Health2020; 20(1): 1596. https://doi.org/10.1186/s12889-020-09639-9
5.
RumsfeldJSAlexanderKPGoffDC, et al.Cardiovascular health: the importance of measuring patient-reported health status. Circulation2013; 127(22): 2233–2249. https://doi.org/10.1161/CIR.0b013e3182949a2e
6.
ZorgeNEScheerdersERYDudinkK, et al.A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (GERAS study). J Eur Acad Dermatol Venereol2023; 37(2): 428–435. https://doi.org/10.1111/jdv.18586
7.
Espaulella-FerrerMEspaulella-PanicotJNoell-BoixR, et al.Assessment of frailty in elderly patients attending a multidisciplinary wound care centre: a cohort study. BMC Geriatr2021; 21(1): 727. https://doi.org/10.1186/s12877-021-02676-y
NelzénOBergqvistDLindhagenA. Long-term prognosis for patients with chronic leg ulcers: a prospective cohort study. Eur J Vasc Endovasc Surg1997; 13(5): 500–508. https://doi.org/10.1016/S1078-5884(97)80179-7
10.
SaleniusJSuntilaMAhtiT, et al.Long-term mortality among patients with chronic ulcers. Acta Derm Venereol2021; 101(5): adv00455. https://doi.org/10.2340/00015555-3803
11.
WuNCChenZCFengIJ, et al.Severe varicose veins and the risk of mortality: a nationwide population-based cohort study. BMJ Open2020; 10(6): e034245. https://doi.org/10.1136/bmjopen-2019-034245
12.
KreftDKeilerJGrambowE, et al.Prevalence and mortality of venous leg diseases of the deep veins: an observational cohort study based on German health claims data. Angiology2020; 71(5): 452–464. https://doi.org/10.1177/0003319720905751
13.
ProchaskaJHArnoldNFalckeA, et al.Chronic venous insufficiency, cardiovascular disease, and mortality: a population study. Eur Heart J2021; 42(40): 4157–4165. https://doi.org/10.1093/eurheartj/ehab495
14.
LurieFPassmanMMeisnerM, et al.The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord2020; 8(3): 342–352. https://doi.org/10.1016/j.jvsv.2019.12.075
15.
VasquezMARabeEMcLaffertyRB, et al.Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American venous forum ad hoc outcomes working group. J Vasc Surg2010; 52(5): 1387–1396. https://doi.org/10.1016/j.jvs.2010.06.161
EngbersMJKarasuABlomJW, et al.Clinical features of venous insufficiency and the risk of venous thrombosis in older people. Br J Haematol2015; 171(3): 417–423. https://doi.org/10.1111/bjh.13579
18.
ChangSLHuangYLLeeMC, et al.Association of varicose veins with incident venous thromboembolism and peripheral artery disease. JAMA2018; 319(8): 807–817. https://doi.org/10.1001/jama.2018.0246
19.
RochonPJReghunathanAKapoorBS, et al.ACR appropriateness criteria® lower extremity chronic venous disease. J Am Coll Radiol2023; 20(11): S481–S500. https://doi.org/10.1016/j.jacr.2023.08.011
20.
KawajiQMartinsonJHusainS, et al.Multidisciplinary limb salvage care is associated with decreased mortality without increasing revascularization in major amputations. J Vasc Surg2025; 82: 1438–1447. https://doi.org/10.1016/j.jvs.2025.04.005
21.
RollinsKEJacksonDCoughlinPA. Meta-analysis of contemporary short- and long-term mortality rates in patients diagnosed with critical leg ischaemia. Br J Surg2013; 100(8): 1002–1008. https://doi.org/10.1002/bjs.9127
22.
AbouAyashJAbduRWKaniaTA, et al.Conditional survival analysis and risk factors for mortality in patients with chronic limb-threatening ischemia. J Vasc Surg2025; 82: 1392–1400.e2. https://doi.org/10.1016/j.jvs.2025.05.004
23.
GuestJFFullerGW. Cohort study assessing the impact of COVID-19 on venous leg ulcer management and associated clinical outcomes in clinical practice in the UK. BMJ Open2023; 13(2): e068845. https://doi.org/10.1136/bmjopen-2022-068845
24.
BuiUTEdwardsHFinlaysonK. Identifying risk factors associated with infection in patients with chronic leg ulcers. Int Wound J2018; 15(2): 283–290. https://doi.org/10.1111/iwj.12867
25.
BuiUTFinlaysonKEdwardsH. Risk factors for infection in patients with chronic leg ulcers: a survival analysis. Int J Clin Pract2018; 72(12): e13263. https://doi.org/10.1111/ijcp.13263
26.
NeemanELiuVMishraP, et al.Trends and risk factors for venous thromboembolism among hospitalized medical patients. JAMA Netw Open2022; 5(11): e2240373. https://doi.org/10.1001/jamanetworkopen.2022.40373
27.
ChristiansenSCCannegieterSCKosterT, et al.Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA2005; 293(19): 2352–2361. https://doi.org/10.1001/jama.293.19.2352
28.
MeulendijksAMde VriesFMCvan DoorenAA, et al.A systematic review on risk factors in developing a first‐time venous leg ulcer. J Eur Acad Dermatol Venereol2019; 33(7): 1241–1248. https://doi.org/10.1111/jdv.15343
29.
JockenhöferFGollnickHHerbergerK, et al.Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1 000 patients from 10 specialised dermatological wound care centers in Germany. Int Wound J2016; 13(5): 821–828. https://doi.org/10.1111/iwj.12387
30.
SlonkováVVaškůAVaškůV. Polymorphisms in some proinflammatory genes (TNFα and β, IL‐1β, IL‐6, ADAM17) in severe chronic venous disease. J Eur Acad Dermatol Venereol2023; 37(3): 590–597. https://doi.org/10.1111/jdv.18770
31.
Zil-E-AliADeHavenCAlamarieB, et al.Black or African American patients undergo great saphenous vein ablation procedures for advanced venous disease and have the least improvement in their symptoms after these procedures. J Vasc Surg Venous Lymphat Disord2023; 11(5): 904–912.e1. https://doi.org/10.1016/j.jvsv.2023.06.002
32.
WahabNTettelbachWHDriverV, et al.The impact of dual-enrolee (Medicare/Medicaid) status on venous leg ulcer outcomes: a retrospective study. J Wound Care2024; 33(12): 886–892. https://doi.org/10.12968/jowc.2024.0174
Duarte JuniorMAPintos CarrilloSMartínez-GómezD, et al.Lifestyle behaviors, social and economic disadvantages, and all-cause and cardiovascular mortality: results from the US national health interview survey. Front Public Health2024; 12. https://doi.org/10.3389/fpubh.2024.1297060
35.
MaqsoodMHNguyenRChangR, et al.Unfavorable social determinants of health and mortality risk by cardiovascular disease status: findings from a national study of United States adults. Am Heart J2024; 267: 95–100. https://doi.org/10.1016/j.ahj.2023.10.006
36.
RaffettoJDLigiDManiscalcoR, et al.Why venous leg ulcers have difficulty healing: overview on pathophysiology, clinical consequences, and treatment. J Clin Med2020; 10(1): 29. https://doi.org/10.3390/jcm10010029
37.
BohannonWTMcLaffertyRBChaneyST, et al.Outcome of venous stasis ulceration when complicated by arterial occlusive disease. Eur J Vasc Endovasc Surg2002; 24(3): 249–254. https://doi.org/10.1053/ejvs.2002.1650
38.
PattonDAvsarPSayehA, et al.A meta‐review of the impact of compression therapy on venous leg ulcer healing. Int Wound J2023; 20(2): 430–447. https://doi.org/10.1111/iwj.13891
39.
ShiCDumvilleJCCullumN, et al.Compression bandages or stockings versus no compression for treating venous leg ulcers. Cochrane Database Syst Rev2021; 2021(7): 13397. https://doi.org/10.1002/14651858.CD013397.pub2
40.
GohelMSMoraMJSzigetiM, et al.Long-term clinical and cost-effectiveness of early endovenous ablation in venous ulceration. JAMA Surg2020; 155(12): 1113. https://doi.org/10.1001/jamasurg.2020.3845
41.
GohelMSHeatleyFLiuX, et al.A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med2018; 378(22): 2105–2114. https://doi.org/10.1056/NEJMoa1801214
42.
KaravanMOlerudJBouldinE, et al.Evidence‐based chronic ulcer care and lower limb outcomes among Pacific northwest veterans. Wound Repair Regen2015; 23(5): 745–752. https://doi.org/10.1111/wrr.12341
43.
WarrinerRAWilcoxJRCarterMJ, et al.More frequent visits to wound care clinics result in faster times to close diabetic foot and venous leg ulcers. Adv Skin Wound Care2012; 25(11): 494–501. https://doi.org/10.1097/01.ASW.0000422629.03053.06
